118 related articles for article (PubMed ID: 27039343)
21. Bacteraemia due to non-ESBL-producing Escherichia coli O25b:H4 sequence type 131: insights into risk factors, clinical features and outcomes.
Morales-Barroso I; López-Cerero L; Molina J; Bellido M; Navarro MD; Serrano L; González-Galán V; Praena J; Pascual A; Rodríguez-Baño J
Int J Antimicrob Agents; 2017 Apr; 49(4):498-502. PubMed ID: 28257756
[TBL] [Abstract][Full Text] [Related]
22. Prc contributes to Escherichia coli evasion of classical complement-mediated serum killing.
Wang CY; Wang SW; Huang WC; Kim KS; Chang NS; Wang YH; Wu MH; Teng CH
Infect Immun; 2012 Oct; 80(10):3399-409. PubMed ID: 22825444
[TBL] [Abstract][Full Text] [Related]
23. [Experimental urinary tract infection caused by Escherichia coli in diabetic mouse--uroepithelial colonization and polymorphonuclear leukocyte function].
Kishi M
Hinyokika Kiyo; 1992 Sep; 38(9):991-8. PubMed ID: 1414765
[TBL] [Abstract][Full Text] [Related]
24. Uropathogenic Escherichia coli as a model of host-parasite interaction.
Svanborg C; Bergsten G; Fischer H; Godaly G; Gustafsson M; Karpman D; Lundstedt AC; Ragnarsdottir B; Svensson M; Wullt B
Curr Opin Microbiol; 2006 Feb; 9(1):33-9. PubMed ID: 16406777
[TBL] [Abstract][Full Text] [Related]
25. Shiga toxin-negative attaching and effacing Escherichia coli: distinct clinical associations with bacterial phylogeny and virulence traits and inferred in-host pathogen evolution.
Bielaszewska M; Middendorf B; Köck R; Friedrich AW; Fruth A; Karch H; Schmidt MA; Mellmann A
Clin Infect Dis; 2008 Jul; 47(2):208-17. PubMed ID: 18564929
[TBL] [Abstract][Full Text] [Related]
26. Comparative study of Escherichia coli virulence determinants in strains causing urinary tract bacteremia versus strains causing pyelonephritis and other sources of bacteremia.
Moreno E; Planells I; Prats G; Planes AM; Moreno G; Andreu A
Diagn Microbiol Infect Dis; 2005 Oct; 53(2):93-9. PubMed ID: 16168618
[TBL] [Abstract][Full Text] [Related]
27. Extraintestinal pathogenic Escherichia coli survives within neutrophils.
Nazareth H; Genagon SA; Russo TA
Infect Immun; 2007 Jun; 75(6):2776-85. PubMed ID: 17296761
[TBL] [Abstract][Full Text] [Related]
28. Identification of a bovine mastitis Escherichia coli subset.
Blum S; Heller ED; Krifucks O; Sela S; Hammer-Muntz O; Leitner G
Vet Microbiol; 2008 Nov; 132(1-2):135-48. PubMed ID: 18571344
[TBL] [Abstract][Full Text] [Related]
29. Molecular markers for detection of pathogenic Escherichia coli strains belonging to serogroups O 138 and O 139.
Wang L; Liu B; Kong Q; Steinrück H; Krause G; Beutin L; Feng L
Vet Microbiol; 2005 Dec; 111(3-4):181-90. PubMed ID: 16280204
[TBL] [Abstract][Full Text] [Related]
30. Escherichia coli virulence factors.
Mainil J
Vet Immunol Immunopathol; 2013 Mar; 152(1-2):2-12. PubMed ID: 23083938
[TBL] [Abstract][Full Text] [Related]
31. Virulence and other phenotypic characteristics of urinary isolates of cysteine-requiring Escherichia coli.
McIver CJ; Tapsall JW
J Med Microbiol; 1995 Jan; 42(1):39-42. PubMed ID: 7739023
[TBL] [Abstract][Full Text] [Related]
32. Effect of culture conditions on the susceptibility of enteroaggregative Escherichia coli to human serum and polymorphonuclear leucocytes.
Haque MA; Kohashi O
Microbios; 1996; 86(349):213-23. PubMed ID: 8893523
[TBL] [Abstract][Full Text] [Related]
33. Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf(1)) attenuates the virulence of uropathogenic Escherichia coli.
Rippere-Lampe KE; O'Brien AD; Conran R; Lockman HA
Infect Immun; 2001 Jun; 69(6):3954-64. PubMed ID: 11349064
[TBL] [Abstract][Full Text] [Related]
34. Occurrence of hlyA and sheA genes in extraintestinal Escherichia coli strains.
Kerényi M; Allison HE; Bátai I; Sonnevend A; Emödy L; Plaveczky N; Pál T
J Clin Microbiol; 2005 Jun; 43(6):2965-8. PubMed ID: 15956433
[TBL] [Abstract][Full Text] [Related]
35. The classical complement pathway plays a critical role in the opsonisation of uropathogenic Escherichia coli.
Li K; Sacks SH; Sheerin NS
Mol Immunol; 2008 Feb; 45(4):954-62. PubMed ID: 17870166
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of antibiotic resistance and phylogenetic group patterns in human and porcine urinary tract infectious Escherichia coli.
Hancock V; Nielsen EM; Krag L; Engberg J; Klemm P
APMIS; 2009 Nov; 117(11):786-90. PubMed ID: 19845528
[TBL] [Abstract][Full Text] [Related]
37. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
Horwitz MA; Silverstein SC
J Clin Invest; 1980 Jan; 65(1):82-94. PubMed ID: 6985617
[TBL] [Abstract][Full Text] [Related]
38. A comparative study of antimicrobial resistance rates and phylogenetic groups of community-acquired versus hospital-acquired invasive Escherichia coli.
Ferjani S; Saidani M; Amine FS; Boutiba Ben Boubaker I
Med Mal Infect; 2015 Apr; 45(4):133-8. PubMed ID: 25725924
[TBL] [Abstract][Full Text] [Related]
39. Pandemic lineages of extraintestinal pathogenic Escherichia coli.
Riley LW
Clin Microbiol Infect; 2014 May; 20(5):380-90. PubMed ID: 24766445
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis.
Davis JM; Carvalho HM; Rasmussen SB; O'Brien AD
Infect Immun; 2006 Aug; 74(8):4401-8. PubMed ID: 16861625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
